avpfl6d

Property	Value
?:abstract	BACKGROUND: Antibiotic therapy has been proposed as an alternative to surgery for the treatment of appendicitis. METHODS: We conducted a pragmatic, nonblinded, noninferiority, randomized trial comparing antibiotic therapy (10-day course) with appendectomy in patients with appendicitis at 25 U.S. centers. The primary outcome was 30-day health status, as assessed with the European Quality of Life-5 Dimensions (EQ-5D) questionnaire (scores range from 0 to 1, with higher scores indicating better health status; noninferiority margin, 0.05 points). Secondary outcomes included appendectomy in the antibiotics group and complications through 90 days; analyses were prespecified in subgroups defined according to the presence or absence of an appendicolith. RESULTS: In total, 1552 adults (414 with an appendicolith) underwent randomization; 776 were assigned to receive antibiotics (47% of whom were not hospitalized for the index treatment) and 776 to undergo appendectomy (96% of whom underwent a laparoscopic procedure). Antibiotics were noninferior to appendectomy on the basis of 30-day EQ-5D scores (mean difference, 0.01 points; 95% confidence interval [CI], -0.001 to 0.03). In the antibiotics group, 29% had undergone appendectomy by 90 days, including 41% of those with an appendicolith and 25% of those without an appendicolith. Complications were more common in the antibiotics group than in the appendectomy group (8.1 vs. 3.5 per 100 participants; rate ratio, 2.28; 95% CI, 1.30 to 3.98); the higher rate in the antibiotics group could be attributed to those with an appendicolith (20.2 vs. 3.6 per 100 participants; rate ratio, 5.69; 95% CI, 2.11 to 15.38) and not to those without an appendicolith (3.7 vs. 3.5 per 100 participants; rate ratio, 1.05; 95% CI, 0.45 to 2.43). The rate of serious adverse events was 4.0 per 100 participants in the antibiotics group and 3.0 per 100 participants in the appendectomy group (rate ratio, 1.29; 95% CI, 0.67 to 2.50). CONCLUSIONS: For the treatment of appendicitis, antibiotics were noninferior to appendectomy on the basis of results of a standard health-status measure. In the antibiotics group, nearly 3 in 10 participants had undergone appendectomy by 90 days. Participants with an appendicolith were at a higher risk for appendectomy and for complications than those without an appendicolith. (Funded by the Patient-Centered Outcomes Research Institute; CODA ClinicalTrials.gov number, NCT02800785.).
is ?:annotates of	<https://research.tib.eu/covid-19/entity/1avpfl6d_hasAnnotation_C0003232> <https://research.tib.eu/covid-19/entity/1avpfl6d_hasAnnotation_C0009566> <https://research.tib.eu/covid-19/entity/1avpfl6d_hasAnnotation_C0027627> <https://research.tib.eu/covid-19/entity/1avpfl6d_hasAnnotation_C1079230>
?:creator	<https://research.tib.eu/covid-19/entity/Flum%2C_David_R%3B_Davidson%2C_Giana_H%3B_Monsell%2C_Sarah_E%3B_Shapiro%2C_Nathan_I%3B_Odom%2C_Stephen_R%3B_Sanchez%2C_Sabrina_E%3B_Drake%2C_F_Thurston%3B_Fischkoff%2C_Katherine%3B_Johnson%2C_Jeffrey%3B_Patton%2C_Joe_H%3B_Evans%2C_Heather%3B_Cuschieri%2C_Joseph%3B_Sabbatini%2C_Amber_K%3B_Faine%2C_Brett_A%3B_Skeete%2C_Dionne_A%3B_Liang%2C_Mike_K%3B_Sohn%2C_Vance%3B_McGrane%2C_Karen%3B_Kutcher%2C_Matthew_E%3B_Chung%2C_Bruce%3B_Carter%2C_Damien_W%3B_Ayoung-Chee%2C_Patricia%3B_Chiang%2C_William%3B_Rushing%2C_Amy%3B_Steinberg%2C_Steven%3B_Foster%2C_Careen_S%3B_Schaetzel%2C_Shaina_M%3B_Price%2C_Thea_P%3B_Mandell%2C_Katherine_A%3B_Ferrigno%2C_Lisa%3B_Salzberg%2C_Matthew%3B_DeUgarte%2C_Daniel_A%3B_Kaji%2C_Amy_H%3B_Moran%2C_Gregory_J%3B_Saltzman%2C_Darin%3B_Alam%2C_Hasan_B%3B_Park%2C_Pauline_K%3B_Kao%2C_Lillian_S%3B_Thompson%2C_Callie_M%3B_Self%2C_Wesley_H%3B_Yu%2C_Julianna_T%3B_Wiebusch%2C_Abigail%3B_Winchell%2C_Robert_J%3B_Clark%2C_Sunday%3B_Krishnadasan%2C_Anusha%3B_Fannon%2C_Erin%3B_Lavallee%2C_Danielle_C%3B_Comstock%2C_Bryan_A%3B_Bizzell%2C_Bonnie%3B_Heagerty%2C_Patrick_J>
?:journal	N_Engl_J_Med
?:license	unk
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/1avpfl6d_HAS_C0003232_TREATS_C0003615>
?:source	WHO
?:title	A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:who_covidence_id	#920642
?:year	2020

Property

Value

?:abstract

BACKGROUND: Antibiotic therapy has been proposed as an alternative to surgery for the treatment of appendicitis. METHODS: We conducted a pragmatic, nonblinded, noninferiority, randomized trial comparing antibiotic therapy (10-day course) with appendectomy in patients with appendicitis at 25 U.S. centers. The primary outcome was 30-day health status, as assessed with the European Quality of Life-5 Dimensions (EQ-5D) questionnaire (scores range from 0 to 1, with higher scores indicating better health status; noninferiority margin, 0.05 points). Secondary outcomes included appendectomy in the antibiotics group and complications through 90 days; analyses were prespecified in subgroups defined according to the presence or absence of an appendicolith. RESULTS: In total, 1552 adults (414 with an appendicolith) underwent randomization; 776 were assigned to receive antibiotics (47% of whom were not hospitalized for the index treatment) and 776 to undergo appendectomy (96% of whom underwent a laparoscopic procedure). Antibiotics were noninferior to appendectomy on the basis of 30-day EQ-5D scores (mean difference, 0.01 points; 95% confidence interval [CI], -0.001 to 0.03). In the antibiotics group, 29% had undergone appendectomy by 90 days, including 41% of those with an appendicolith and 25% of those without an appendicolith. Complications were more common in the antibiotics group than in the appendectomy group (8.1 vs. 3.5 per 100 participants; rate ratio, 2.28; 95% CI, 1.30 to 3.98); the higher rate in the antibiotics group could be attributed to those with an appendicolith (20.2 vs. 3.6 per 100 participants; rate ratio, 5.69; 95% CI, 2.11 to 15.38) and not to those without an appendicolith (3.7 vs. 3.5 per 100 participants; rate ratio, 1.05; 95% CI, 0.45 to 2.43). The rate of serious adverse events was 4.0 per 100 participants in the antibiotics group and 3.0 per 100 participants in the appendectomy group (rate ratio, 1.29; 95% CI, 0.67 to 2.50). CONCLUSIONS: For the treatment of appendicitis, antibiotics were noninferior to appendectomy on the basis of results of a standard health-status measure. In the antibiotics group, nearly 3 in 10 participants had undergone appendectomy by 90 days. Participants with an appendicolith were at a higher risk for appendectomy and for complications than those without an appendicolith. (Funded by the Patient-Centered Outcomes Research Institute; CODA ClinicalTrials.gov number, NCT02800785.).

is ?:annotates of